The NFL and NFL Players Association agreed to a population test study to conduct among NFL players for human growth hormone to gauge the right amount for a positive test.
Testing hasn't been implemented, but it's getting closer.
Here's a copy of the memo distributed to NFLPA membership regarding the study obtained by National Football Post:
TO: NFLPA Membership
RE: HGH Population Study
The NFLPA and NFL have agreed to conduct a population study of NFL players for human growth hormone (hGH) to determine the proper decision limit for a positive test under the NFL/NFLPA Performance Enhancing Substances drug policy. Dr. Alan Rogol, M.D., Ph.D has been jointly hired by the NFLPA and NFL to oversee the study and supervise two jointly retained biostatisticians. One biostatistician, Donald Berry, Ph.D., will design the study protocol and conduct the analysis, and a second biostatistician will independently review both the protocol and the analysis. This is the scientific analysis to determine the appropriate decision limits for our Members that we have insisted upon since the signing of the CBA.
Every player will provide a blood sample for the population study during the pre-season training camp physicals. The blood sample from each player will immediately be sent to the laboratory for analysis only for the purpose of the hGH population study; no other use will be made of any blood sample. After the laboratory has processed all player blood samples, the scientists will perform the calculations and analysis necessary to determine the proper decision limit for NFL players.
There are, however, several additional issues which must be collectively bargained to agreement before final implementation of the hGH and Performance Enhancing Substances drug policy. One of those issues is the issue of discipline. The parties continue to discuss the issue and when a final proposal is reached, we will bring it to you for your review and vote.”
Follow me on Twitter: @RavensInsider
Aaron Wilson covers the Ravens for The Baltimore Sun